GBIO Generation Bio Co

  1. Stocks
  2. Healthcare
  3. NASDAQ: GBIO

Price (delayed)

$2.78

Market cap

$184.81M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.96

Enterprise value

$210.46M

Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent ...

Highlights
The gross profit has soared by 95% from the previous quarter
GBIO's revenue has surged by 95% since the previous quarter
The net income has grown by 7% YoY but it has contracted by 2.2% from the previous quarter
The quick ratio has plunged by 54% YoY and by 24% from the previous quarter
The equity has decreased by 28% YoY and by 12% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://generationbio.com
Peers: OCX OGEN OLMA OMER

Key stats

What are the main financial stats of GBIO
Market
Shares outstanding
66.48M
Market cap
$184.81M
Enterprise value
$210.46M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.9
Price to sales (P/S)
30.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
35.65
Earnings
Revenue
$5.9M
EBIT
-$126.61M
EBITDA
-$121.35M
Free cash flow
-$60.14M
Per share
EPS
-$1.96
Free cash flow per share
-$0.93
Book value per share
$3.07
Revenue per share
$0.09
TBVPS
$5.81
Balance sheet
Total assets
$374.76M
Total liabilities
$171.63M
Debt
$97.89M
Equity
$203.13M
Working capital
$232.7M
Liquidity
Debt to equity
0.48
Current ratio
6.83
Quick ratio
6.87
Net debt/EBITDA
-0.21
Margins
EBITDA margin
-2,055.4%
Gross margin
100%
Net margin
-2,144.5%
Operating margin
-2,346.9%
Efficiency
Return on assets
-31.8%
Return on equity
-52.3%
Return on invested capital
-36.5%
Return on capital employed
-37.8%
Return on sales
-2,144.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GBIO stock price

How has the Generation Bio stock price performed over time
Intraday
-6.71%
1 week
-30.5%
1 month
-6.08%
1 year
-35.05%
YTD
68.48%
QTD
-31.7%

Financial performance

How have Generation Bio's revenue and profit performed over time
Revenue
$5.9M
Gross profit
$5.9M
Operating income
-$138.56M
Net income
-$126.61M
Gross margin
100%
Net margin
-2,144.5%
The gross profit has soared by 95% from the previous quarter
GBIO's revenue has surged by 95% since the previous quarter
Generation Bio's net margin has increased by 48% from the previous quarter
GBIO's operating margin is up by 47% since the previous quarter

Growth

What is Generation Bio's growth rate over time

Valuation

What is Generation Bio stock price valuation
P/E
N/A
P/B
0.9
P/S
30.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
35.65
Generation Bio's EPS has increased by 17% YoY
The equity has decreased by 28% YoY and by 12% QoQ
The P/B is 3% below the last 4 quarters average of 1.0
GBIO's revenue has surged by 95% since the previous quarter

Efficiency

How efficient is Generation Bio business performance
Generation Bio's ROS has increased by 48% from the previous quarter
Generation Bio's ROIC has increased by 23% YoY
Generation Bio's ROE has decreased by 21% YoY and by 11% from the previous quarter
The ROA has grown by 4.5% YoY but it has contracted by 2.3% from the previous quarter

Dividends

What is GBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GBIO.

Financial health

How did Generation Bio financials performed over time
Generation Bio's total assets is 118% higher than its total liabilities
GBIO's total liabilities has surged by 83% year-on-year and by 15% since the previous quarter
The quick ratio has plunged by 54% YoY and by 24% from the previous quarter
Generation Bio's debt is 52% less than its equity
Generation Bio's debt to equity has surged by 66% YoY and by 41% QoQ
The equity has decreased by 28% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.